Intervention Review

Pramipexole for levodopa-induced complications in Parkinson's disease

  1. Carl E Clarke1,*,
  2. Julie Speller2,
  3. J A Clarke2

Editorial Group: Cochrane Movement Disorders Group

Published Online: 24 APR 2000

Assessed as up-to-date: 23 JAN 2000

DOI: 10.1002/14651858.CD002261


How to Cite

Clarke CE, Speller J, Clarke JA. Pramipexole for levodopa-induced complications in Parkinson's disease. Cochrane Database of Systematic Reviews 2000, Issue 2. Art. No.: CD002261. DOI: 10.1002/14651858.CD002261.

Author Information

  1. 1

    City Hospital, Sandwell and West Birmingham Hospitals NHS Trust, Department of Neurology, Birmingham, West Midlands, UK

  2. 2

    Birmingham, UK

*Carl E Clarke, Department of Neurology, City Hospital, Sandwell and West Birmingham Hospitals NHS Trust, Dudley Road, Birmingham, West Midlands, B18 7QH, UK. c.e.clarke@bham.ac.uk.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 24 APR 2000

SEARCH